Phase II Trial of Ribociclib in Combination With Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2017
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary)
- Indications Leiomyosarcoma; Liposarcoma
- Focus Therapeutic Use
- 13 Oct 2017 Status changed from not yet recruiting to recruiting.
- 12 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.
- 06 Jun 2017 Planned initiation date changed from 1 May 2017 to 1 Jun 2017.